Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine
European Journal of Surgical Oncology 47(8) (2021)
Zainul Abedin Kapacee; Mairéad G. McNamara; Nicola de Liguori Carino; Angela Lamarca; Juan W. Valle; Richard A. Hubner
Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine
European Journal of Surgical Oncology 47(8) (2021)
Markus Wilhelmi
Immunotherapy in hepatocellular carcinoma
Annals of Hepatology 18(2) (2019)
Luigi Buonaguro; Angela Mauriello; Beatrice Cavalluzzo; Annacarmen Petrizzo; Maria Tagliamonte
Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells
Oncology Letters (2019)
Changjiang Lei; Defa Ren; Meixia Fu; Chuantao Sun; Hong Ren; Qingyun Pan; Yuan Li
Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology
Clinical Colorectal Cancer 20(3) (2021)
Linda Beenet
RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma
Clinical and Experimental Medicine 22(2) (2021)
Yue Li; Xiaoqin He; Xiaoyu Zhang; Yangtao Xu; Wenliang Chen; Xin Liu; Ximing Xu
Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats
F1000Research 11 (2022)
Andry Irawan; Erik Prabowo; Ignatius Riwanto; Wahyuni Lukita Atmodjo
Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation
Technology in Cancer Research & Treatment 22 (2023)
Renguo Guan; Jie Mei; Rongping Guo
Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats
F1000Research 11 (2022)
Andry Irawan; Erik Prabowo; Ignatius Riwanto; Wahyuni Lukita Atmodjo
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
Hepatic Oncology 5(1) (2018)
Francesco Tovoli; Giulia Negrini; Francesca Benevento; Chiara Faggiano; Elisabetta Goio; Alessandro Granito
Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma
Canadian Journal of Gastroenterology and Hepatology 2021(1) (2021)
Wei Sun; Yongchao Zhang; Bozhi Liu; Youjia Duan; Wei Li; Jinglong Chen
A New CYP2E1 Inhibitor, 12‐Imidazolyl‐1‐dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
Canadian Journal of Gastroenterology and Hepatology 2021(1) (2021)
Torsten Diesinger; Alfred Lautwein; Sebastian Bergler; Dominik Buckert; Christian Renz; Radovan Dvorsky; Vyacheslav Buko; Siarhei Kirko; Edith Schneider; Florian Kuchenbauer; Mukesh Kumar; Cagatay Günes; Felicitas Genze; Berthold Büchele; Thomas Simmet; Martin Haslbeck; Kai Masur; Thomas Barth; Dieter Müller-Enoch; Thomas Wirth; Thomas Haehner
Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma
Journal of Oncology 2021 (2021)
Dongyu Wu; Guangcong Zhang; Jiamei Ma; Hongfen Wu; Ju Xiong; Xiaoxi Huang; Yuanyuan Tian; Taozhi Deng; Xiangyang Han; Xiaoning Sun; Tian Xiang; Xiangnan Yu; Xuemei Jiang
The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma
Journal of Oncology 2021 (2021)
Hao Zhang; Renzheng Liu; Lin Sun; Weidong Guo; Xiao Hu
Combinatorial immunotherapy strategies for hepatocellular carcinoma
Current Opinion in Immunology 39 (2016)
Maria Tagliamonte; Annacarmen Petrizzo; Maria Lina Tornesello; Gennaro Ciliberto; Franco M Buonaguro; Luigi Buonaguro
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
Journal of Cancer Research and Clinical Oncology 144(2) (2017)
Franco Trevisani; Giovanni Brandi; Francesca Garuti; Maria Aurelia Barbera; Raffaella Tortora; Andrea Casadei Gardini; Alessandro Granito; Francesco Tovoli; Stefania De Lorenzo; Andrea Lorenzo Inghilesi; Francesco Giuseppe Foschi; Mauro Bernardi; Fabio Marra; Rodolfo Sacco; Giovan Giuseppe Di Costanzo
Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
Science Progress 104(3) (2021)
Jihan Wang; Yangyang Wang; Jing Xu; Qiying Song; Jingbo Shangguan; Mengju Xue; Hanghui Wang; Jingyi Gan; Wenjie Gao
Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer
Journal of Chemotherapy 37(5) (2024)
Feng Ju; Kaixia Chen; Dengyang Yin
Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience
SpringerPlus 5(1) (2016)
Amr Shaaban Hanafy
Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Journal of Gastrointestinal Cancer 55(4) (2024)
Nandini Gupta; Neelkant Verma; Bhoomika Patel
Distribution of Breast Density in Iranian Women and its Association with Breast Cancer Risk Factors
Iranian Red Crescent Medical Journal 15(12) (2013)
Nasrin Ahmadinejad; Sajjadeh Movahedinia; Samaneh Movahedinia; Kourosh Holakouie Naieni; Saharnaz Nejat
A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma
Frontiers in Immunology 13 (2022)
Guanghao Li; Yongheng Liu; Yanting Zhang; Yao Xu; Jin Zhang; Xianfu Wei; Zhongmin Zhang; Chao Zhang; Jinyan Feng; Qiang Li; Guowen Wang
BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
Cancer Medicine 12(14) (2023)
Hiroyuki Abe; Kenya Kamimura; Shujiro Okuda; Yu Watanabe; Jun Inoue; Yutaka Aoyagi; Toshifumi Wakai; Ryo Kominami; Shuji Terai
Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
Frontiers in Oncology 11 (2021)
Tin-Yun Tang; Katherine Daunov; Richard T. Lee
Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo
Experimental Biology and Medicine 241(13) (2016)
Chia-Hung Lin; Ching-Yao Chang; Kuan-Rong Lee; Hui-Ju Lin; Wu-Chou Lin; Ter-Hsin Chen; Lei Wan
Metronomics: Potential Social Impact and New Business Models to Improve Availability of Cancer Treatments
Metronomic Chemotherapy (2014)
Yuliya Snihur; Eddy Pasquier; Graciela Scharovsky; Nicolas Andre
Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma
International Journal of Molecular Sciences 22(6) (2021)
Jianrong Zheng; Liao Zeng; Mingqing Tang; Hongjun Lin; Chao Pi; Ruian Xu; Xiuling Cui
CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
Frontiers in Oncology 11 (2021)
Bowen Li; Shibo Wei; Liang Yang; Xueqiang Peng; Yingbo Ma; Bo Wu; Qing Fan; Shuo Yang; Xinyu Li; Hongyuan Jin; Shilei Tang; Mingyao Huang; Hangyu Li; Jingang Liu
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure
Digestive and Liver Disease 47(6) (2015)
Alessandro Granito; Sara Marinelli; Eleonora Terzi; Fabio Piscaglia; Matteo Renzulli; Laura Venerandi; Francesca Benevento; Luigi Bolondi
Potentiating cancer vaccine efficacy in liver cancer
OncoImmunology 7(10) (2018)
Maria Tagliamonte; Annacarmen Petrizzo; Angela Mauriello; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review
Mini-Reviews in Medicinal Chemistry 22(6) (2022)
Amit Kumar; Ankit Siwach; Prabhakar Verma